GRAYBUG VISION INC (GRAY) Stock Price, Quote, News and Overview
NASDAQ:GRAY - Nasdaq - US38942Q1031 - Common Stock - Currency: USD
GRAY Quote, Performance and Key Statistics
5.5
-0.67 (-10.8%)
The current stock price of GRAY is 5.5 USD. In the past month the price decreased by -37.39%. In the past year, price decreased by -69.78%.
GRAY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About GRAY
Company Profile
Graybug Vision Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Redwood City, California and currently employs 8 full-time employees. The company went IPO on 2020-09-25. Graybug Vision, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases. The firm's products include GB-102 and GB-401. GB-102 is a lead product designed to provide pan-vascular endothelial growth factor (VEGF) inhibition for six months or longer while minimizing fluctuations in retinal thickness in between treatments. GB-102 is a once-every-six month intravitreal injection for the treatment of wet age-related macular degeneration (wet AMD). The firm is also evaluating and developing GB-102 for the treatment of diabetic retinopathy (DR). GB-401, is an intravitreally administered, proprietary implant formulation containing a prodrug of a beta-adrenergic receptor inhibitor designed to provide a controlled release of the active drug to maintain reduced intraocular pressure (IOP) for six months or longer after a single injection for the treatment of primary open-angle glaucoma.
Company Info
GRAYBUG VISION INC
274 Redwood Shores Parkway, P.O. Box 144
Redwood City CALIFORNIA 94065 US
CEO: Frederic Guerard
Employees: 8
Company Website: http://www.graybug.com/
Phone: 16504872800.0
GRAYBUG VISION INC / GRAY FAQ
What is the stock price of GRAYBUG VISION INC today?
The current stock price of GRAY is 5.5 USD. The price decreased by -10.8% in the last trading session.
What is the ticker symbol for GRAYBUG VISION INC stock?
The exchange symbol of GRAYBUG VISION INC is GRAY and it is listed on the Nasdaq exchange.
On which exchange is GRAY stock listed?
GRAY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GRAYBUG VISION INC stock?
6 analysts have analysed GRAY and the average price target is 42.84 USD. This implies a price increase of 678.91% is expected in the next year compared to the current price of 5.5. Check the GRAYBUG VISION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GRAYBUG VISION INC worth?
GRAYBUG VISION INC (GRAY) has a market capitalization of 617.26K USD. This makes GRAY a Nano Cap stock.
How many employees does GRAYBUG VISION INC have?
GRAYBUG VISION INC (GRAY) currently has 8 employees.
What are the support and resistance levels for GRAYBUG VISION INC (GRAY) stock?
GRAYBUG VISION INC (GRAY) has a resistance level at 7.62. Check the full technical report for a detailed analysis of GRAY support and resistance levels.
Should I buy GRAYBUG VISION INC (GRAY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GRAY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GRAY, evaluating the profitability, health, valuation and growth aspects
- GRAYBUG VISION INC (GRAY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GRAYBUG VISION INC (GRAY) Sales and EPS estimates to see what analysts future expectations are.
- GRAYBUG VISION INC (GRAY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GRAYBUG VISION INC (GRAY) Insider and Institutional Ownership to learn about the owners and their transactions.
- GRAYBUG VISION INC (GRAY) Stock Chart to make your own analysis
- GRAYBUG VISION INC (GRAY) Latest news and press-releases to stay up to date.
Does GRAYBUG VISION INC (GRAY) stock pay dividends?
GRAY does not pay a dividend.
When does GRAYBUG VISION INC (GRAY) report earnings?
GRAYBUG VISION INC (GRAY) will report earnings on 2023-05-08.
What is the Price/Earnings (PE) ratio of GRAYBUG VISION INC (GRAY)?
GRAYBUG VISION INC (GRAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.66).
GRAY Technical Analysis
GRAY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GRAY. While GRAY seems to be doing ok healthwise, there are quite some concerns on its profitability.
GRAY Financial Highlights
Over the last trailing twelve months GRAY reported a non-GAAP Earnings per Share(EPS) of -1.66. The EPS increased by 1.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
GRAY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to GRAY. The Buy consensus is the average rating of analysts ratings from 6 analysts.